Drugs / Arginine recovery supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03204266 | Aug 2017 → May 2022 | malignant urinary system neoplasm | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arginine recovery supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03204266 ↗ |